← Back to Clinical Trials
Recruiting NCT06738823

NCT06738823 Effect of Wii Fit Training in Comparison to Vestibular Rehabilitation Training on Balance in Patients With Benign Paroxysmal Postional Vertigo

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06738823
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Benign Paroxysmal Positional Vertigo
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2024-07-20
Primary Completion 2024-12-01

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
INTERVENTION GROUP : TRAINING WITH WIIFITVESTIBULAR REHABILITATION TRAINING

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2024-07-20 with a primary completion date of 2024-12-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

THIS STUDY IS A RANDOMIZED CONTROL TRIAL AND THE PURPOSE OF THE STUDY IS TO DETERMINE THE EFFECT OF WIIFIT TRAINING IN COMPARISON TO VESTIBULAR REHAB TRAINING ON BALANCE IN PATIENTS WITH BENIGN PAROXYSMAL POSITIONAL VERTIGO

Eligibility Criteria

Inclusion Criteria: * Patients diagnosed with benign paroxysmal positional vertigo. * Aged 30-60 years. * Ability to stand and walk independently. * Male and Female * Positive Dix Hallpike Test * DHI Scale: 36-42 (moderate Handicap) Exclusion Criteria: * patients with history of vestibular surgery or cochlear implantation. * Patients with history of seizures or epilepsy. * patients with a pacemaker or implantable cardioverter-defibrillator(ICD). * Patients with history of severe head injury or concussion within the past year. * No other vestibular disorders or conditions that may affect balance.

Contact & Investigator

Central Contact

MAHAM AKBAR, DPT

✉ mahamakbarch25@gmail.com

📞 +92334-6406143

Frequently Asked Questions

Who can join the NCT06738823 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Benign Paroxysmal Positional Vertigo. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06738823 currently recruiting?

Yes, NCT06738823 is actively recruiting participants. Contact the research team at mahamakbarch25@gmail.com for enrollment information.

Where is the NCT06738823 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT06738823 clinical trial?

NCT06738823 is sponsored by Foundation University Islamabad. The trial plans to enroll 38 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology